Chronic secondary musculoskeletal pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age, sex, and underlying disease are not limited. Patients diagnosed with chronic secondary musculoskeletal pain during outpatient visits. Patients who have provided consent to receive extracorporeal shock wave therapy (ESWT). Patients who have provided consent to participate in the study. In cases where the patient is unable to sign due to any reason, verbal consent or proxy consent will be accepted.
Exclusion criteria
Exclusion criteria: Patients whom the investigator judges to be inappropriate for inclusion in the study. Patients with any lesion (e.g., malignant tumor, metastasis, or fracture) within 5 cm of the planned ESWT treatment site. Patients who develop skin disorders of CTCAE Grade 2 after ESWT. Patients who refuse ESWT after enrollment. Patients with severe cognitive impairment or psychiatric disorders that make appropriate evaluation difficult. Patients with a high risk of bleeding, such as those with coagulation disorders or taking anticoagulant medications. Patients with cardiovascular devices (e.g., pacemaker) located at or near the planned treatment site. Patients with local infection or purulent lesions at the planned treatment site. Patients who are pregnant or may be pregnant. Patients with severe osteoporosis who have an extremely high risk of fracture.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in pain intensity assessed by the Numerical Rating Scale (NRS) before and after ESWT. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in range of motion (ROM) | — |
Countries
Japan
Contacts
Saitama Medical University Hospital palliative care team